MINNEAPOLIS, Aug. 28, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announced that management will be presenting virtually at the H.C. Wainwright 25th Annual Global Investment Conference. Interested parties may access the…Read More
Panbela to Present at HC Wainwright 25th Annual Global Investment Conference
